Interim / Quarterly Report • Aug 19, 2025
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
January–June
Ambea AB (publ) Corp. Reg. No. 556468-4354
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
∆% | 2025 Jan–Jun |
2024 Jan–Jun |
∆% | RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 4,088 | 3,519 | 16 | 7,732 | 7,003 | 10 | 14,924 | 14,195 |
| Adjusted EBITA* | 311 | 271 | 15 | 618 | 550 | 12 | 1,440 | 1,372 |
| Operating margin, adjusted EBITA (%)* | 7.6 | 7.7 | 8.0 | 7.9 | 9.6 | 9.7 | ||
| EBITA* | 286 | 271 | 6 | 563 | 550 | 2 | 1,385 | 1,372 |
| Operating margin, EBITA (%)* | 7.0 | 7.7 | 7.3 | 7.9 | 9.3 | 9.7 | ||
| Operating profit, EBIT | 274 | 248 | 10 | 538 | 504 | 7 | 1,312 | 1,278 |
| Operating margin, EBIT (%)* | 6.7 | 7.0 | 7.0 | 7.2 | 8.8 | 9.0 | ||
| Profit for the period | 95 | 95 | 0 | 212 | 206 | 3 | 626 | 620 |
| Earnings per share before dilution, SEK | 1.13 | 1.10 | 3 | 2.53 | 2.35 | 8 | 7.46 | 7.21 |
| Earnings per share after dilution, SEK | 1.13 | 1.09 | 3 | 2.53 | 2.34 | 8 | 7.44 | 7.20 |
| Cash conversion (%)* | 93.8 | 102.5 | 82.5 | 100.2 | 89.8 | 97.9 | ||
| Free cash flow* | 425 | 458 | −7 | 688 | 872 | −21 | 1,782 | 1,966 |
*Alternative performance measures. For reconciliation of financial statements to IFRS, see Note 8. For purpose and definition, see https://ambea.com/investor-relations/reports/key-financial-figures-definitions/
| Introduction | 2 | Validia |
13 |
|---|---|---|---|
| Quality and sustainability4 | Altiden14 | ||
| Reporting |
7 | Klara and Lära | 15 |
| Group7 | Group financial statements |
19 | |
| Nytida10 | Parent Company financial statements |
23 | |
| Vardaga 11 |
Notes | 25 | |
| Stendi12 |
We reported a strong trend during the quarter, with clear growth in sales and earnings. A significant part of this growth was driven by Validia, which we took over on 1 April and is now included in our quarterly reporting for the first time. The acquisition has met all of our expectations so far, and we are impressed by the competence and commitment shown by Validia's employees and management. With high occupancy and stable profitability, we see good opportunities for Validia's future development.
In Sweden, we acquired the care company AvAsta in the Gothenburg region during the quarter, consisting of a nursing home with 90 beds in Vardaga and four care units in Nytida with a total of 64 beds. I would like to welcome all of our new employees and care receivers to Ambea!
Ambea has by far the strongest pipeline of new care places in the Nordic region, and it continued to grow during the quarter as we opened three new care units and completed an expansion corresponding to a total of 29 care places. We also signed rental contracts for four new care units and further expansions including a total of 119 additional care places. We constantly strive to support the community by expanding care services and meeting the sharply increasing need for new care places in the coming years.
Organic growth was 5 per cent, and all business areas noted a positive trend during the quarter. However, earnings were impacted to varying degrees by Easter and currency effects, which means the figures do not fully reflect the underlying positive development we see in our operations.
Vardaga delivered another good and stable quarter.
Altiden continues to improve and delivered positive earnings during the quarter. Altiden is entering a new phase following the new Elderly Care Reform that became effective in Denmark on 1 July. The reform creates a much better environment for start-up units under own management, and we are actively looking for opportunities to establish new nursing homes in Denmark.
Nytida is continuing to open new care units in areas with good demand, while work is proceeding to adapt operations to the new Social Services Act in Sweden. With the implemented adjustments, we expect the margin to stabilise at a slightly higher level in the coming quarters.
For Stendi, the quarter was slightly weaker year-onyear, mainly because Easter fell in the second quarter, which as expected impacted profitability in Norway more than in the other Nordic countries. Compared with previous year, we noted a slightly lower but more normal level of demand, which we will be able to meet with a healthy margin going forward.
The integration of Validia is on track, and we are actively seeking opportunities to establish new care units and to make bolt-on acquisitions in Finland, for which we have allocated resources earlier than expected.
Ambea plays an important role in the public debate. With operations in four Nordic countries and as one of the sector's largest players, we actively participate in discussions that concern the future of care and the challenges we face. I recently became Chairman ofthe Association of Private Care Providers, our Swedish employer and industry organisation. The organisation contributes to a relevant and constructive debate on industrial policy in Sweden, not least ahead ofthe 2026 elections. At the
same time, the general election in Norway is approaching and Ingvild Kristiansen, Managing Director of Stendi, is taking part in the debate through her involvement in the Norwegian National Association for Health Industry, Welfare and Education (NHO Geneo), where she was elected Chair of the Health and Welfare section during the quarter. We are also active members of
national trade associations in Finland and Denmark.
By showing how care can be developed based on quality, competence and a long-term approach, we want to be a responsible voice at a time when the need for care in the Nordic region is growing and the solutions must be shaped together.
We know that quality of care starts with committed employees. It was therefore gratifying to see that the results our latest employee Net Promoter Score (eNPS) survey, where we ask our employees if they would recommend Ambea as an employer, remained stable. I am proud that our determined efforts to strengthen participation, skills development and local leadership are continuing to yield results.
During the quarter, we placed a particular focus on diversity and inclusion, important factors in creating

We constantly strive to support the community by expanding care services and meeting the sharply increasing need for new care places in the coming years.
welcoming environments for both employees and care receivers. As a Bronze Partner of Stockholm Pride, our business areas in Sweden took part in the celebrations, both in the parade in Stockholm and through local initiatives at our care units. By raising issues concerning norms, identity and inclusion, we want to contribute to a safe working environment where everyone can be themselves within the framework of our core values.
With committed employees and a responsible culture, we are creating sustainable growth that enables investment and safe care for more people. Thank you to all of our employees who every day make the world a better place, one person at a time.
Mark Jensen, President and CEO Ambea
Quality and sustainability
Our mission is to create enough safe and sustainable care for all. To achieve this, we have established a robust quality management system that permeates all areas of our operations. Our approach to quality management is based on our vision, our values and the skills of our employees. We also have clear systems and procedures to support this approach. The aim is that it should be easy for employees to do the right thing, and to spend their time on the right things – care that creates quality of life and value. We use a Quality Index to monitor our units on a monthly basis. The index consists of eight selected quality and HR metrics that show us the status of each unit, and allow us to monitor our units systematically. Validia has an established quality reporting system that is gradually being adapted to the Group's standard. The aim is to include Validia in the Group's overall quality reporting in conjunction with the quarterly report for the fourth quarter of 2025.
For sustainability issues, we work with an established Environmental, Social and Governance (ESG) framework that encompasses all of our sustainability practices and performance.
EWe are working actively to achieve climate-smart care. This means that we are working to reduce the carbon footprint of our food, consumables, premises and transportation. We have adopted an ambitious tar-
*Tonnes of CO₂eq per unit of revenue, excluding employee commuting.
get to halve our emissions by 2025 compared with 2019. We have submitted our emissions-reduction targets to the Science Based Targets initiative for validation and will thus have a scientifically validated plan in place from 2026 to guide us in the climate transition.
SSocial sustainability is ingrained in our DNA. In this area, we are focused on quality, leadership, health and safety, diversity and inclusion, and on spreading knowledge and developing the skills of our own and the sector's employees.
GOur operations are characterised by robust control, transparency and trust, based on compliance with internal and external regulations and procedures. We participate in public debate with our knowledge and use our size to influence society and our sector.
By working actively with quality and sustainability, we are contributing to social development and helping to future-proof care.

We want to be a responsible voice at a time when the need for care in the Nordic region is growing.

During the quarter, we recognised European Diversity Month and placed a particular focus on diversity and inclusion in our operations. Our involvement in Pride was an important part of this work.
This year, Ambea, together with Vardaga, Nytida and Klara, was a Bronze Partner of Stockholm Pride. Vardaga was also a Gold Sponsor of Malmö Pride. We want our annual participation in Pride, as well as conversations and activities in our operations, to raise awareness and create safe, inclusive environments for both our employees and our residents.
"We encouraged our units across the country to celebrate Pride and, during the period, had a particular focus on how we can visualise and speak about norms, inclusion and identity in our day-to-day interactions," says Elin Delvert, Head of HR at Ambea.
Vardaga Norrgården celebrated Diversity Month and Pride with a popular gathering that included rainbow muffins, quizzes, and music.

The year's first self-assessment was carried out in May. A comprehensive battery of questions is used to review each unit's compliance with applicable legislation and Ambea's internal procedures. The results are used to identify areas for improvement, and form the basis
for further local development efforts. They are also followed up at business area level to provide support where needed. Validia was not part of this year's self-assessment, but will be included in the future.
In November 2024, Validia launched a campaign to collect discarded textiles in collaboration with the Finnish company Globe Hope. The recycled textiles are transformed into new products for internal use, such as acoustic panels
and support cushions. In spring 2025, the first recycled products were delivered to Validia's care units throughout Finland. The collaboration is part of Validia's commitment to a circular economy.

Glada Midnattsloppet, Alzheimerloppet, Holmenkollenstafetten and Nytidaspelen. During the quarter, we encouraged physical activity through several initiatives and partnerships that promote health in our units.
The proportion of employees who would recommend Ambea as an employer remains high. In the spring eNPS survey, we achieved a score of +26 (excluding Validia), a good result that reflects our long-term efforts related to leadership and development opportunities.
During the spring, Stendi conducted a pilot project in collaboration with ABEL, a company that offers digital health guidance via an app and video. The aim was to help employees achieve a better balance in their daily lives and ultimately reduce sick leave.
The results showed that participants experienced increased energy, better sleep and improved perceived health. Completion rates were high and the participants were satisfied.
As the next step, Stendi is taking part in a national study led by SINTEF, one of Europe's largest independent research institutes, in which another 300 employees will be offered digital health guidance. The aim is to increase knowledge about how this type of intervention can contribute to better health and lower sick leave.
Ambea's KPIs for quality and social sustainability (excluding Validia)
| Target | Outcome Q2 2025 |
Outcome Q2 2024 |
Comments | |
|---|---|---|---|---|
| Ambea's Quality Index An aggregated score of eight quality and HR KPIs. Scale of 1–10 |
>7.50 | 7.83 | 7.72 | Ambea's Quality Index rose to 7.83 year-on-year from 7.72. Altiden accounted for the largest improvement, driven by several targeted quality initiatives. Vardaga, Nytida and Stendi remained stable with a slightly positive trend, which confirms the impact of the ongoing long-term improvement process. |
| Partial report of Ambea's Quality Index 1 Perceived care Care receivers' view of our care and service. Scale of 1–100 |
>87% | 88% | 89% | The national customer surveys in Sweden and internal surveys in Stendi and Altiden con firm a continued stable experience among our care receivers. Overall, Ambea maintains the same level of customer satisfaction as the year-earlier period. |
| 2 Employee satisfaction Employee satisfaction surveys are carried out on a regular basis during the year to measure satisfaction and engagement. Scale of 0–100 |
>75 | 74 | 74 | Our latest employee survey shows that employee satisfaction remains at a high level, unchanged compared with the year-earlier quarter. Compared with the previous survey (March 2025), the score increased by one point. The survey is conducted six times per year and provides valuable insights into how our employees perceive their working envi ronment. The high score confirms that our employees are thriving, and we continuously strive to follow up and further develop our strengths. |
| 3 Leadership Index The employees' view of leadership at Ambea. Scale of 0–100 |
>80 | 78* | 78 | The survey is conducted twice per year, and the most recent was carried out in the first quarter of 2025. The score remained unchanged compared with the year-earlier period. The survey is based on an in-depth assessment in which employees evaluate their line manager based on Ambea's prioritised leadership areas. The scores is based on an aver age of all individual responses to various leadership questions. |
| 4 Recommendation of Ambea Whether the employee would recommend Ambea as an employer. eNPS scale -100 – +100 |
>+20 | +26 | +26 The number of employees who would recommend Ambea as an employer remains unchanged at a high level. We are continuing to listen to and act on feedback from our employees, with a particular focus on leadership, career opportunities and skills devel opment. Our vision to make the world a better place, one person at a time, also applies to our employees. |
|
| 5 Internal control Control and follow-up of a unit's compliance with the quality management system. Scale of 0–2 |
>1.85 | 1.88 | 1.86 | All units in all business areas have carried out self-assessment according to plan. The overall result for Ambea improved slightly year-on-year. Self-assessments are used as a tool to identify areas for improvement and are followed up at both local and central level. |
| 6 Improvement Index Improvements implemented and documented in the units. Scale of 0–10 |
>7.50 | 7.50 | 7.54 | The Improvement Index – which reflects the extent to which identified improvements are being implemented – remained stable for Ambea as a whole. Altiden showed a clear increase in its Improvement Index, driven by the quality-oriented efforts implemented in the business area. Stendi, Nytida and Vardaga retained their scores with a slight decline year-on-year, which is being further analysed to ensure the pace and accuracy of the improvement work. |
* Outcome is unchanged compared with the preceding quarter, since no new survey was carried out during the quarter.
Reporting
Net sales rose 16 per cent to SEK 4,088 million (3,519). Organic growth was 5 per cent, acquired/divested growth was 13 per cent, and currency effect was −2 per cent.
Net sales in own management rose 19 per cent to SEK 3,300 million (2,768). The growth was largely due to the newly acquired Validia business area in Finland. Acquisitions and start-up units in Nytida also contributed, as did increased occupancy in Vardaga.
Net sales in contract management amounted to SEK 733 million (689). The increased sales were attributable to newly started contracts in Vardaga and Nytida.
Net sales in competence and staffing solutions amounted to SEK 55 million (62). The decrease was attributable to challenges related to demand for staffing services in Klara.
Adjusted EBITA rose 15 per cent to SEK 311 million (271). The earnings improvement was driven by the acquired Validia business area together with higher occupancy in Vardaga and improved earnings in Altiden. Calendar effects, particularly in Stendi, offset the earnings improvement.
All business areas were negatively impacted, to varying degrees, by increased costs for unconvenient working hours over the Easter weekend compared with the preceding year when Easter fell in the first quarter.
The adjusted EBITA margin was 7.6 per cent (7.7). EBITA rose 6 per cent to SEK 286 million (271). Items affecting comparability in the quarter amounted to SEK 25 million, which refer to transaction and integration costs linked to the acquisition of Validia. The EBITA margin was 7.0 per cent (7.7). EBIT rose 10 per cent to SEK 274 million (248), representing a margin of 6.7 per cent (7.0).
Net financial expense for the quarter was SEK –136 million (–118). Of this amount, SEK –92 million (–79) pertained to interest on lease liabilities, SEK –41 million (–40) to interest and financial expenses/income, and SEK –3 million (1) to exchange rate fluctuations.
Tax expense for the period was SEK –43 million (–35), corresponding to an effective tax rate of 31 per cent (27), impacted by non-deductible acquisition costs of SEK 56 million.
Profit for the period totalled SEK 95 million (95), corresponding to earnings per share of SEK 1.13 (1.10) before dilution and SEK 1.13 (1.09) after dilution.
Free cash flow for the quarter amounted to SEK 425 million (458). Free cash flow, excluding IFRS 16 effects, amounted to SEK 115 million (186). Cash flow was negatively affected by two non-recurring items. These items pertained to the settlement of a provision from 2021 for a dispute in Norway and payments linked to the acquisition of Validia. In total, these items amounted to SEK 106 million.


Reporting
Net sales rose 10 per cent to SEK 7,732 million (7,003). Organic growth was 5 per cent, acquired/divested growth was 7 per cent, and currency/calendar effect was –2 per cent. The comparative period was positively impacted by the leap day.
Net sales in own management rose 13 per cent to SEK 6,178 million (5,468). The growth was largely due to the newly acquired business area in Finland – Validia. Acquisitions and start-up units in Nytida also contributed, as did increased occupancy in Vardaga.
Net sales in contract management amounted to SEK 1,446 million (1,411). The increased sales were attributable to newly started contracts in Vardaga and Nytida, but were offset by contracts terminated in Stendi.
Net sales in competence and staffing solutions amounted to SEK 108 million (124). The decrease was attributable to challenges related to demand for staffing services in Klara.
Adjusted EBITA rose 12 per cent to SEK 618 million (550). The earnings improvement was driven by the acquired Validia business area together with higher occupancy in Vardaga and improved earnings in Altiden. Nytida and calendar effects, particularly in Stendi, offset the earnings improvement.
The comparative period was positively impacted by the leap day.
The adjusted EBITA margin was 8.0 per cent (7.9). EBITA rose 2 per cent to SEK 563 million (550). Items affecting comparability in the quarter amounted to SEK 55 million, which refer to transaction and integration costs linked to the acquisition of Validia. The EBITA margin was 7.3 per cent (7.9). EBIT rose 7 per cent to SEK 538 million (504) representing a margin of 7.0 per cent (7.2).
Net financial expense for the quarter was SEK –250 million (–233). Of this amount, SEK –173 million (–158) pertained to interest on lease liabilities, SEK –71 million (–73) to interest and financial expenses/income, and SEK –6 million (–3) to exchange rate fluctuations.
Tax expense for the period was SEK –76 million (–65), corresponding to an effective tax rate of 26 per cent (24), impacted by non-deductible acquisition costs of SEK 56 million.
Profit for the period totalled SEK 212 million (206), corresponding to earnings per share of SEK 2.53 (2.35) before dilution and SEK 2.53 (2.34) after dilution.
Free cash flow for the quarter amounted to SEK 688 million (872). Free cash flow, excluding IFRS 16 effects, amounted to SEK 99 million (332). Cash flow was negatively affected by two non-recurring items. These items pertained to the settlement of a provision from 2021 for a dispute in Norway and payments linked to the acquisition of Validia. In total, these items amounted to SEK 106 million.

Introduction Quality and sustainability Reporting
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| EBITDA* | 650 | 590 | 1,257 | 1,183 | 2,719 | 2,645 |
| Adjustment for non-cash items | −1 | −8 | −11 | −27 | −65 | −81 |
| Change in working capital | −10 | 40 | −137 | 60 | −90 | 107 |
| Cash flow from investments in fixed assets1 | −29 | −32 | −72 | −47 | −125 | −100 |
| Operating cash flow, including investments to increase capacity* | 610 | 590 | 1,037 | 1,169 | 2,439 | 2,571 |
| Net interest paid | −136 | −111 | −255 | −237 | −485 | −467 |
| Tax paid | −49 | −21 | −94 | −60 | −172 | −138 |
| Free cash flow* | 425 | 458 | 688 | 872 | 1,782 | 1,966 |
| Acquisitions of subsidiaries and investment in financial instruments | −1,178 | −72 | −1,179 | −72 | −1,365 | −258 |
| Cash flow from financing activities | 973 | −374 | 706 | −767 | −214 | −1,687 |
| Cash flow for the period | 220 | 12 | 215 | 33 | 203 | 21 |
| 1) of which sales of fixed assets | 1 | 2 | 1 | 12 | 6 | 17 |
| Operating cash flow excluding IFRS 16 effects* | 209 | 239 | 275 | 471 | 966 | 1,162 |
| Free cash flow, excluding IFRS 16 effects* | 115 | 186 | 99 | 332 | 642 | 875 |
| Excl. IFRS 16 effects | Incl. IFRS 16 effects | |||||||
|---|---|---|---|---|---|---|---|---|
| SEK million | 2025 30 June |
2024 30 June |
2024 31 Dec |
2025 30 June |
2024 30 June |
2024 31 Dec |
||
| Net interest-bearing debt* | 3,545 | 2,324 | 2,098 | 13,432 | 11,371 | 11,027 | ||
| Rolling 12 months adjusted EBITDA* | 1,301 | 1,101 | 1,237 | 2,774 | 2,467 | 2,645 | ||
| Net debt/Rolling 12-months adjusted EBITDA* | 2.7 | 2.1 | 1.7 | 4.8 | 4.6 | 4.2 |
*Alternative performance measures. For reconciliation of financial statements to IFRS, purpose and definition see ambea.com/investor-relations/reports/key-financial-figures-definitions/

Net sales per contract model
April–June 2025

Nytida provides support and care for children, youth and adults with lifelong disabilities and psychosocial problems. We offer residential facilities, daily activity units, support for individuals and families, and schools for more than 5,000 care receivers in around 470 units across Sweden. Using proven models and in-depth knowledge, our employees help to strengthen the ability of individuals to live an independent life.
Nytida acquired parts of AvAsta during the quarter, with annual sales of SEK 62 million. In addition to the acquisition, Nytida opened a new care unit with six care places and signed a contract for another care unit with the same capacity.
Net sales rose 10 per cent year-on-year to SEK 1,150 million (1,044). Net sales in own management amounted to SEK 929 million (841). Growth was driven by acquired and start-up units, but was partly
offset by occupancy challenges in some parts of the Individual and family care operations.
Net sales in contract management amounted to SEK 221 million (203). The increase was linked to price indexation and a positive net effect between start-up and terminated management contracts.
EBITA increased year-on-year to SEK 127 million (124). The positive change was due to favourable results in previous acquisitions but continued to be offset by the occupancy challenges in Individual and family care. Work is ongoing to tailor service offerings and in some care units to adapt to services with higher demand.
The EBITA margin was 11.0 per cent (11.9).
The acquired parts of AvAsta include four units providing 64 care places for adults with lifelong disabilities and psychosocial problems.

Net sales rose 9 per cent year-on-year to SEK 2,272 million (2,086). Net sales in own management amounted to SEK 1,840 million
(1,675). The increase was driven by acquired and start-up units. Occupancy challenges in parts of the Individual and family care service offering offset the increase.
Net sales in contract management amounted to SEK 432 million (411). The increase was mainly attributable to price indexation.
EBITA declined year-on-year to SEK 245 million (249). The decrease in earnings is due to the occupancy challenges in Individual and family care. Work is ongoing to tailor service offerings and in some care units to adapt to services with higher demand. The comparative period was positively impacted by calendar effects.
The EBITA margin was 10.8 per cent (11.9).
391
Number of beds and care places opened under own management (RTM), where 326 are derived from acquisitions and 65 from newly opened units.


| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
∆% | 2025 Jan–Jun |
2024 Jan–Jun |
∆% | RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 1,150 | 1,044 | 10 | 2,272 | 2,086 | 9 | 4,435 | 4,249 |
| EBITA* | 127 | 124 | 2 | 245 | 249 | −2 | 534 | 538 |
| Operating margin, EBITA (%)* |
11.0 | 11.9 | 10.8 | 11.9 | 12.0 | 12.7 |
At Vardaga's over 100 nursing homes across Sweden, we offer elderly care where every day matters. We provide around 8,000 care receivers with expertise and safety in our nursing homes, and in home care. Our employees work to ensure quality of life and a sense of security for each individual.
Vardaga acquired a nursing home with 90 beds from AvAsta during the quarter, with annual sales of SEK 82 million. Control of the company was transferred on 5 May 2025.
During the quarter, a contract was also signed to increase capacity by 30 beds at a planned nursing home in Täby.
Net sales rose 8 per cent year-on-year to SEK 1,358 million (1,262). Net sales in own management amounted to SEK 932 million (865). The growth was attributable to acquisition along with continued higher occupancy.
Net sales in contract management amounted to SEK 426 million (397), up 7 per cent. The increase was due to a positive net effect between start-up and terminated management contracts.
EBITA rose 10 per cent to SEK 115 million (105). The improved earnings were driven by higher occupancy.
The EBITA margin was 8.5 per cent (8.3).
Net sales rose 7 per cent year-on-year to SEK 2,671 million (2,493). Net sales in own management amounted to SEK 1,830 million
(1,709). The increase was due to higher occupancy in new and established nursing homes.
Net sales in contract management amounted to SEK 841 million (784), up 7 per cent. The increase was due to a positive net effect

between start-up and terminated management contracts. EBITA rose 9 per cent to SEK 226 million (208). Earnings were driven by increased occupancy. The comparative period was positively impacted by calendar effects.
The EBITA margin was 8.5 per cent (8.3).

Number of beds opened under own management (RTM). All are the result of acquisitions.

**Mature units do not include nursing homes under own management that were opened after Q2 2023, or nursing homes that are not yet open.
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
∆% | 2025 Jan–Jun |
2024 Jan–Jun |
∆% | RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 1,358 | 1,262 | 8 | 2,671 | 2,493 | 7 | 5,265 | 5,087 |
| EBITA* | 115 | 105 | 10 | 226 | 208 | 9 | 509 | 491 |
| Operating margin, EBITA (%)* |
8.5 | 8.3 | 8.5 | 8.3 | 9.7 | 9.7 | ||
| Operating margin, EBITA mature units (%)* |
9.9 | 9.8 | 9.9 | 9.7 | 11.0 | 11.0 |
Stendi is the largest care provider in Norway and runs nationwide operations in disability and psychosocial care for adults, children and youth. We have about 850 care receivers and more than 300 units across Norway, and are working every day to strengthen individuals and create quality of life.
During the quarter, Stendi opened two new care units with a total of 18 beds and expanded an existing unit with an additional five beds. In addition, contracts were signed to add another five beds in existing units. In parallel, the structure was reviewed and seven smaller units, with a total of 16 beds, have been closed.
Net sales decreased 2 per cent to SEK 823 million (840). Sales rose 4 per cent in local currency. All operations in Stendi are carried out under own management.
The increase was driven by a change in the mix of services provided, whereby care with higher compensation accounted for a larger share.
EBITA was SEK 29 million (61). The negative deviation was mainly driven by increased costs for inconvenient working hours linked to the Easter holidays, which fell in the first quarter of the previous year. This had a particular impact in Norway. Higher variation in occupancy also impacted staffing efficiency compared with the year-earlier period.
The EBITA margin was 3.5 per cent (7.3).
Net sales decreased 2 per cent to SEK 1,646 million (1,677). Sales rose 2 per cent in local currency.
Net sales in own management amounted to SEK 1,646 million (1,643). Sales rose 4 per cent in local currency.

The increase was driven by a change in the mix of services provided, whereby care with higher compensation accounted for a larger share.
Net sales in contract management amounted to SEK – million (34). In 2024, Stendi terminated all contract management operations, which were exclusive within elderly care.
EBITA was SEK 97 million (120). Earnings for the period were impacted by higher variation in occupancy and lower staffing efficiency.
The EBITA margin was 5.9 per cent (7.2).
59 Number of beds under own management under construction.

| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
∆% | 2025 Jan–Jun |
2024 Jan–Jun |
∆% | RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 823 | 840 | −2 | 1,646 | 1,677 | −2 | 3,321 | 3,352 |
| EBITA* | 29 | 61 | −52 | 97 | 120 | −19 | 311 | 334 |
| Operating margin, EBITA (%)* |
3.5 | 7.3 | 5.9 | 7.2 | 9.4 | 10.0 |
Validia is Ambea's Finnish business area and offers care and residential facilities for people with physical and intellectual disabilities, neurological injuries and psychosocial problems. Validia has approximately 50 units across Finland and more than 2,600 employees.
Validia became part of Ambea on 1 April 2025, and this is therefore the first quarter it is included in Ambea's reporting. This means that comparative figures for the year-earlier period are unavailable. Validia has had a strong start in Ambea, and we see several opportunities for continued development going forward. During the quarter, Validia signed contracts to open two new care units with a total capacity of 78 beds. The units are scheduled to open in 2026 in regions with high demand, with 60 and 18 beds respectively.
The integration of Validia is proceeding as planned. The work is divided into a number of clearly defined areas, several of which have already been completed. Early successes include the integration of Validia into Ambea's operational financial processes, the inclusion of Validia in Ambea's application to the Science Based Targets initiative, and the launch of a new graphic profile for Validia. We have aligned the structure of the establishment and acquisition process with Ambea's growth model and allocated extra resources to accelerate growth in Finland.
Net sales amounted to SEK 375 million. All operations in Validia are carried out under own management.
EBITA was SEK 39 million. Despite this being its seasonally weakest quarter, Validia demonstrated strong earnings with a good margin.
The EBITA margin was 10.4 per cent.
As this is Validia's first quarter in Ambea, the cumulative figures are the same as for the quarter.


(approx.)

counties as clients.
or cognitive disabilities. Several facilities offer extra care and round-the-clock accommodation.
Specialised rehabilitation for people with brain and spinal cord injuries and neurological disorders, focusing on personalised rehabilitation plans.
Assistance providing people with severe disabilities an opportunity to live an independent life.
A wide range of daily activities and support for people with disabilities – to strengthen participation, independence and companionship.
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
∆% | RTM |
|---|---|---|---|---|
| Net sales | 375 | – | 375 | |
| EBITA* | 39 | – | 39 | |
| Operating margin, EBITA (%)* | 10.4 | – | 10.4 |
Altiden is the largest private care provider in Denmark, with about 50 units in elderly care, disability care and social care. We have about 750 care receivers, and work to ensure quality of life for each individual, with a focus on security and development.
Increased occupancy and the ongoing restructuring work resulted in another quarter with a clear improvement in earnings.
Net sales rose 5 per cent to SEK 327 million (311). Sales rose 10 per cent in local currency.
Net sales in own management amounted to SEK 241 million (222). The increase was driven by higher occupancy in both social and elderly care.
Net sales in contract management amounted to SEK 86 million (89). Sales rose 1 per cent in local currency.
EBITA was SEK 1 million (–13). The positive change was due to the good occupancy growth together with operational improvements in social care.
The EBITA margin was 0.3 per cent (–4.2).
Net sales rose 6 per cent to SEK 660 million (624). Sales rose 9 per cent in local currency.
Net sales in own management amounted to SEK 487 million (441). The increase was driven by higher occupancy in both social and elderly care.
Net sales in contract management amounted to SEK 173 million (182). Sales declined 2 per cent in local currency. The decrease was due to one elderly care contract that was handed back.
EBITA was SEK 9 million (–22). The increase was due to the good

occupancy growth together with operational improvements in social care.
The EBITA margin was 1.4 per cent (–3.5).
514 Number of beds and care places in operation under own management.


| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
∆% | 2025 Jan–Jun |
2024 Jan–Jun |
∆% | RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 327 | 311 | 5 | 660 | 624 | 6 | 1,309 | 1,273 |
| EBITA* | 1 | −13 | – | 9 | −22 | – | 44 | 13 |
| Operating margin, EBITA (%)* |
0.3 | −4.2 | 1.4 | −3.5 | 3.4 | 1.0 |
Klara is one of the leading providers of staffing solutions for schools and elderly and social care in Sweden, with a focus on staffing, mobile nursing teams and student health services.
Lära is one of the leading providers in Sweden in training and skills development for social work, care, healthcare, schools and therapy.
At SEK 104 million (104), net sales were in line with the year-earlier period. The positive trend in student health services offset the continued weak demand for nurse staffing.
EBITA increased to SEK 9 million (5). Klara has adjusted its cost base to reflect a structurally lower market demand, which resulted in a positive earnings trend.
The EBITA margin was 8.7 per cent (4.8).
Net sales decreased 2 per cent to SEK 204 million (209). The change was due to weaker demand for nurse staffing.
EBITA rose 21 per cent to SEK 17 million (14). Klara has adjusted its cost base to reflect a structurally lower market demand, which resulted in a positive earnings trend.
The EBITA margin was 8.3 per cent (6.7).


9.4 per cent (RTM).

| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
∆% | 2025 Jan–Jun |
2024 Jan–Jun |
∆% | RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|---|---|
| Net sales | 104 | 104 | 0 | 204 | 209 | −2 | 404 | 409 |
| EBITA* | 9 | 5 | 80 | 17 | 14 | 21 | 38 | 35 |
| Operating margin, EBITA (%)* |
8.7 | 4.8 | 8.3 | 6.7 | 9.4 | 8.6 |
| SEK million | 2025 Q2 |
2025 Q1 |
2024 Q4 |
2024 Q3 |
2024 Q2 |
|---|---|---|---|---|---|
| Ambea | |||||
| Number of beds and care places in operation under own management on the closing date |
11,726 | 10,227 | 10,241 | 9,991 | 9,957 |
| Number of beds and care places opened under own man agement (RTM) |
107 | 282 | 268 | 322 | 380 |
| Number of beds and care places under own management under construction |
1,360 | 1,285 | 1,308 | 1,283 | 1,272 |
| Confirmed management contract start-ups/terminations, SEK million* |
–107 | –8 | 31 | 140 | 88 |
| Nytida | |||||
| Number of beds and care places in operation under own management |
5,488 | 5,420 | 5,427 | 5,174 | 5,133 |
| Number of beds and care places opened under own man agement (RTM) |
65 | 89 | 60 | 61 | 45 |
| Number of beds and care places under own management under construction |
137 | 143 | 167 | 171 | 167 |
| Confirmed management contract start-ups/terminations, SEK million* |
4 | 20 | –3 | 44 | 25 |
| Vardaga | |||||
| Number of beds in operation under own management | 3,665 | 3,621 | 3,625 | 3,625 | 3,625 |
| Number of beds opened under own management (RTM) | – | 160 | 160 | 160 | 220 |
| Number of beds under own management under construc tion |
1,086 | 1,056 | 1,056 | 1,060 | 1,056 |
| Confirmed management contract start-ups/terminations, SEK million* |
–73 | 10 | 34 | 96 | 63 |
| SEK million | 2025 Q2 |
2025 Q1 |
2024 Q4 |
2024 Q3 |
2024 Q2 |
|---|---|---|---|---|---|
| Stendi | |||||
| Number of beds in operation under own management | 687 | 671 | 674 | 672 | 679 |
| Number of beds opened under own management (RTM) | 42 | 28 | 43 | 57 | 54 |
| Number of beds under own management under construc tion |
59 | 86 | 85 | 52 | 49 |
| Validia | |||||
| Number of beds in operation under own management | 1,372 | – | – | – | – |
| Number of beds opened under own management (RTM) | – | – | – | – | – |
| Number of beds under own management under construc tion |
78 | – | – | – | – |
| Altiden | |||||
| Number of beds and care places in operation under own management |
514 | 515 | 515 | 520 | 520 |
| Number of beds and care places opened under own man agement (RTM) |
– | 5 | 5 | 44 | 61 |
| Number of beds and care places under own management under construction |
– | – | – | – | – |
| Confirmed management contract start-ups/terminations, SEK million* |
–38 | –38 | – | – | – |
*Net of confirmed contract management start-ups/terminations in the coming 12 months. Adjustments have been made in Q3 2024.
Through the acquisition of Aleris Omsorg in 2019, Ambea has been party to an ongoing legal proceeding in Norway regarding costs for temporary staff. Historically, Aleris had used a considerable number of consultants to staff some of its units. Since the acquisition of Aleris, Ambea has been working actively to increase the proportion of permanent employees in the operations. In 2021, a judgment was handed down in favour of the temporary consultants, granting them the right to additional compensation for overtime, holidays and pension for the time they were engaged as consultants. A subsequent proceeding has been ongoing regarding the limitation periods for some of the compensation. In the fourth quarter of 2021, Ambea made a provision of SEK 145 million to cover estimated additional claims and legal costs. During the quarter, a large part of the previous provision (SEK 51 million) was settled. At 30 June 2025, the current remaining provision for known and unknown claims amounted to SEK 36 million.
In 2018, Ambea received a reassessment notice from the Swedish Tax Agency regarding VAT of SEK 12 million, including tax surcharges but excluding interest, for prior years in Ambea AB (publ). No provision was made for these costs. The reassessment was mainly related to input VAT on costs arising from the IPO in 2017. The company appealed the Swedish Tax Agency's decision to the Administrative Court. The Administrative Court ruled in favour of the Swedish Tax Agency's decision, so Ambea appealed to a higher court in 2021. At 30 June 2025, the tax dispute amounted to SEK 14 million, including interest.
During the quarter, there were no transactions between Ambea and related parties with any material impact on the company's position and earnings. The nature and volume of transactions remained unchanged during the period compared with the preceding year.
Ambea's operating profit is affected by seasonal variations, weekends and public holidays.
Weekends and public holidays reduce Ambea's profitability due to higher personnel costs for inconvenient working hours. Most of the public holidays in countries where the company operates normally fall in the second quarter. In some years, Easter may fall in the first quarter and then affect its profitability. Christmas and New Year affect the first and fourth quarters.
The company's personnel costs are affected in a similar manner when employees take out their holidays. For example, the company is most profitable in the third quarter, as employees usually take their holidays during July and August and therefore receive holiday pay that is continuously accrued throughout the year. Costs during the summer months are also generally lower due to a reduced schedule for central activities, such as mandatory training programmes and central initiatives, during this period.
During the quarter, the average number of full-time employees (FTEs) was 16,811 (14,704), and the increase was due to acquired and start-up units.
The total number of shares was 84,101,290. During the quarter, 6,000,000 treasury shares were cancelled and 2,000,000 treasury shares were used as part payment for the acquisition of Validia. Accordingly, Ambea no longer holds any shares in treasury. During the quarter, senior executives and other key people exercised warrants to subscribe for 247,017 new shares.
Ambea is exposed to a variety of risks and attaches great importance to continuously analysing, minimising and managing these risks. The risk assessment is also a key element of the annual strategy process, where risks in relation to the company's ability to achieve its financial targets and strategic ambitions are specifically evaluated. Ambea has identified a number of risks in the categories of competitive risks, operational risks and risks associated with governance. For a description of the specific risks and how they are managed, refer to pages 50–52 of the 2024 Annual Report. The company's risks and uncertainties are deemed to be unchanged compared to those described in the 2024 Annual Report.
This report has not been audited.
The Board of Directors and CEO hereby provide their assurance that this interim report provides a true and fair view of the operations, financial position and earnings of the Parent Company and the Group, and describes the material risks and uncertainties facing the Parent Company and the companies in the Group.
The content of this interim report was adopted on 18 August 2025.
Stockholm, 18 August 2025
Yrjö Närhinen Chair of the Board
Erik Malmberg Board member
Roger Hagborg Board member
Dan Olsson Board member
Patricia Briceño Employee representative Gunilla Rudebjer Board member
Charalampos Kalpakas Employee representative
Mark Jensen President and CEO
Hilde Britt Mellbye Board member
Samuel Skott Board member
Magnus Sällström Employee representative
Ambea will hold a presentation for the financial market, with the possibility to participate by phone, at 10:00 a.m. CEST on Tuesday, 19 August 2025. The presentation will be held in English, and available as a webcast at ambea.se or via Direct Link: edge.media-server.com/mmc/p/za7im36z
The quarterly report and related presentation will be available at ambea.com/investor-relations/reports/reports-and-presentations/
To join the conference call, register before the call using the number link below. When you register, you will receive a dial-in number and a unique dial-in PIN. To make sure your connection to the conference call works, please call ten minutes before the conference call is due to start.
register-conf.media-server.com/register/BI61614bf233c04765a5b2ecc69812c777
Susanne Vogt, Head of IR, Reporting & Group Business Control [email protected]
This information is such that Ambea AB (publ) is obliged to publish pursuant to the EU Market Abuse Regulation.
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Operating income | ||||||
| Net sales | 4,088 | 3,519 | 7,732 | 7,003 | 14,924 | 14,195 |
| Other operating income | 43 | 43 | 77 | 84 | 155 | 162 |
| Operating income | 4,131 | 3,562 | 7,809 | 7,087 | 15,079 | 14,357 |
| Operating expenses | ||||||
| Consumables | −139 | −122 | −262 | −238 | −516 | −492 |
| Other external costs | −396 | −334 | −764 | −682 | −1,414 | −1,332 |
| Personnel costs | −2,947 | −2,516 | −5,529 | −4,985 | −10,435 | −9,891 |
| Depreciation, amortisation and impairment of assets | −376 | −342 | −719 | −679 | −1,407 | −1,367 |
| Other operating expenses | 1 | 0 | 3 | 1 | 5 | 3 |
| Operating expenses | −3,857 | −3,314 | −7,271 | −6,583 | −13,767 | −13,079 |
| Operating profit | 274 | 248 | 538 | 504 | 1,312 | 1,278 |
| Financial income | 0 | 0 | 0 | 0 | 0 | 0 |
| Financial expenses | −136 | −118 | −250 | −233 | −483 | −466 |
| Net financial items | −136 | −118 | −250 | −233 | −483 | −466 |
| Profit before tax | 138 | 130 | 288 | 271 | 829 | 812 |
| Tax on profit for the period | −43 | −35 | −76 | −65 | −203 | −192 |
| Profit for the period | 95 | 95 | 212 | 206 | 626 | 620 |
| Profit for the period attributable to shareholders of the Parent Company |
95 | 95 | 212 | 206 | 626 | 620 |
| Earnings per share before dilution, SEK | 1.13 | 1.10 | 2.53 | 2.35 | 7.46 | 7.21 |
| Earnings per share after dilution, SEK | 1.13 | 1.09 | 2.53 | 2.34 | 7.44 | 7.20 |
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Jun |
|---|---|---|---|---|---|---|
| Profit for the period after tax | 95 | 95 | 212 | 206 | 626 | 620 |
| Other comprehensive income, items not transferable to profit or loss |
||||||
| Remeasurement of defined-benefit pension plans | 0 | −28 | 14 | −28 | 40 | −2 |
| Tax related to remeasurement of defined-benefit pension plans |
||||||
| 0 | 6 | −3 | 6 | −9 | 0 | |
| Total items not transferable to profit or loss | 0 | −22 | 11 | −22 | 31 | −2 |
| Other comprehensive income, items transferable to profit or loss |
||||||
| Translation differences | 6 | 17 | −25 | 20 | −52 | −7 |
| Hedging of net investments in foreign operations | 0 | −3 | 17 | −8 | 28 | 3 |
| Cash flow hedges | −11 | −2 | −10 | 2 | −11 | 1 |
| Cash flow hedge reserve | −1 | −3 | 0 | −13 | −1 | −14 |
| Remeasurement of tenant-owned apartments | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 2 | 2 | −2 | 4 | −4 | 2 |
| Total items transferable to profit or loss | −4 | 11 | −20 | 5 | −40 | −15 |
| Total other comprehensive income | −4 | −11 | −9 | −17 | −9 | −17 |
| Total comprehensive income for the period | 91 | 84 | 203 | 189 | 617 | 603 |
| Comprehensive income for the period attributable to shareholders of the Parent Company |
91 | 84 | 203 | 189 | 617 | 603 |
| 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Dec |
|
|---|---|---|---|---|---|---|
| Profit for the period attributable to shareholders of the Parent Company, SEK million |
95 | 95 | 212 | 206 | 626 | 620 |
| Earnings per share before dilution Average number of shares, thousands |
83,987 | 86,621 | 83,671 | 87,742 | 83,921 | 85,945 |
| Earnings per share before dilution, SEK | 1.13 | 1.10 | 2.53 | 2.35 | 7.46 | 7.21 |
| Earnings per share after dilution Average number of shares, thousands |
84,194 | 86,789 | 83,871 | 87,870 | 84,103 | 86,139 |
| Earnings per share after dilution, SEK | 1.13 | 1.09 | 2.53 | 2.34 | 7.44 | 7.20 |
| SEK million | 2025 30 June |
2024 30 June |
2024 31 Dec |
|---|---|---|---|
| Assets | |||
| Fixed assets | |||
| Goodwill | 8,585 | 7,088 | 7,211 |
| Customer contracts and customer relationships | 241 | 272 | 262 |
| Other intangible assets | 24 | 28 | 25 |
| Right-of-use assets | 9,411 | 8,620 | 8,496 |
| Tangible assets | 369 | 304 | 325 |
| Derivative instruments | – | 13 | 9 |
| Surplus in funded pension plans | 23 | – | 10 |
| Deferred tax assets | 220 | 146 | 179 |
| Non-current receivables | 151 | 130 | 132 |
| Total fixed assets | 19,024 | 16,601 | 16,649 |
| Current assets | |||
| Accounts receivable | 1,485 | 1,343 | 1,284 |
| Other receivables | 104 | 98 | 83 |
| Prepaid expenses and accrued income | 476 | 440 | 431 |
| Cash and cash equivalents | 247 | 39 | 28 |
| Total current assets | 2,312 | 1,920 | 1,826 |
| Total assets | 21,336 | 18,521 | 18,475 |
| SEK million | 2025 30 June |
2024 30 June |
2024 31 Dec |
|---|---|---|---|
| Equity and liabilities | |||
| Equity | |||
| Share capital | 2 | 2 | 2 |
| Other capital contributions | 6,175 | 6,175 | 6,175 |
| Reserves | −61 | −34 | −53 |
| Retained earnings, including profit for the year | −1,098 | −1,448 | −1,138 |
| Total equity | 5,018 | 4,695 | 4,986 |
| Non-current liabilities | |||
| Non-current interest-bearing liabilities | 1,793 | 1,790 | 1,087 |
| Lease liabilities | 8,584 | 7,930 | 7,791 |
| Derivative instruments | 3 | – | – |
| Other non-interest-bearing liabilities | 18 | 15 | 20 |
| Pension provisions | 0 | 16 | 10 |
| Other provisions | 11 | 88 | 12 |
| Deferred tax liabilities | 303 | 224 | 279 |
| Total non-current liabilities | 11,715 | 10,063 | 9,199 |
| Current liabilities | |||
| Current interest-bearing liabilities | 1,003 | – | – |
| Commercial papers | 996 | 573 | 1,039 |
| Lease liabilities | 1,303 | 1,117 | 1,138 |
| Accounts payable | 330 | 425 | 403 |
| Other provisions | 26 | 2 | 76 |
| Tax liabilities | 117 | 82 | 127 |
| Other non-interest-bearing liabilities | 202 | 162 | 180 |
| Accrued expenses and deferred income | 1,629 | 1,402 | 1,327 |
| Total current liabilities | 4,603 | 3,763 | 4,290 |
| Total equity and liabilities | 21,336 | 18521 | 18,475 |
| SEK million | 2025 Jan–Jun |
2024 Jan–Jun |
2024 Jan–Dec |
|---|---|---|---|
| Opening balance | 4,986 | 4,920 | 4,920 |
| Comprehensive income | 203 | 189 | 603 |
| New share issue | 14 | – | 23 |
| Warrants issued | – | 1 | 1 |
| Share buybacks | −219 | −285 | −431 |
| Exercise of repurchased shares | 219 | – | – |
| Dividends | −185 | −130 | −130 |
| Closing balance | 5,018 | 4,695 | 4,986 |
Consolidated cash flow statement in summary
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Operating activities | ||||||
| Operating profit | 274 | 248 | 538 | 504 | 1,312 | 1,278 |
| Depreciation, amortisation and impairment | 376 | 342 | 719 | 679 | 1,407 | 1,367 |
| Capital gains/losses | −2 | −1 | −4 | −6 | −18 | −20 |
| Changes in provisions | 1 | −7 | −7 | −21 | −47 | −61 |
| Total non-cash items | 375 | 334 | 708 | 652 | 1,342 | 1,286 |
| Net interest paid | −136 | −111 | −255 | −237 | −485 | −467 |
| Tax paid | −49 | −21 | −94 | −60 | −172 | −138 |
| Cash flow from operating activities before changes in work ing capital |
464 | 450 | 897 | 859 | 1,997 | 1,959 |
| Cash flow from changes in working capital | ||||||
| Decrease/increase in receivables | −81 | −38 | −98 | −90 | 22 | 30 |
| Decrease/increase in current liabilities | 71 | 78 | −39 | 150 | −112 | 77 |
| Cash flow from operating activities | 454 | 490 | 760 | 919 | 1,907 | 2,066 |
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Investing activities | ||||||
| Acquisition of tangible assets | −27 | −31 | −67 | −50 | −122 | −105 |
| Acquisition of intangible assets | −3 | −3 | −6 | −9 | −9 | −12 |
| Sale of fixed assets | 1 | 2 | 1 | 12 | 6 | 17 |
| Acquisition of subsidiaries | −1,176 | −72 | −1,177 | −72 | −1,358 | −253 |
| Investments in financial instruments | −2 | – | −2 | – | −7 | −5 |
| Cash flow from investing activities | −1,207 | −104 | −1,251 | −119 | −1,490 | −358 |
| Cash flow after investments | −753 | 386 | −491 | 800 | 417 | 1,708 |
| Financing activities Loans raised |
1,900 | 623 | 3,146 | 1,270 | 5,363 | 3,487 |
| Repayment of debt | −1,048 | −647 | −2,185 | −1,435 | −3,957 | −3,207 |
| Repayment of lease liabilities | −310 | −273 | −589 | −541 | −1,140 | −1,092 |
| Net change in checking account | 603 | 221 | 725 | 353 | 34 | −338 |
| New share issue | 14 | – | 14 | – | 37 | 23 |
| Cost of loans raised | −1 | – | −1 | – | −1 | – |
| Premiums for warrants | – | 1 | – | 1 | – | 1 |
| Share buybacks | – | −169 | −219 | −285 | −365 | −431 |
| Dividends paid | −185 | −130 | −185 | −130 | −185 | −130 |
| Cash flow from financing activities | 973 | −374 | 706 | −767 | −214 | −1,687 |
| Cash flow for the period | 220 | 12 | 215 | 33 | 203 | 21 |
| Cash and cash equivalents on the opening date | 25 | 28 | 28 | 6 | 28 | 6 |
| Exchange rate differences in cash and cash equivalents | 2 | −1 | 4 | – | 5 | 1 |
| Cash and cash equivalents on the closing date | 247 | 39 | 247 | 39 | 236 | 28 |
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Operating income | ||||||
| Net sales | 23 | 0 | 23 | 0 | 23 | 0 |
| Operating income | 23 | 0 | 23 | 0 | 23 | 0 |
| Operating expenses | ||||||
| Other external costs | −3 | −6 | −37 | −10 | −44 | −17 |
| Personnel costs | −4 | −4 | −9 | −9 | −16 | −16 |
| Amortisation of intangible assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating expenses | −7 | −10 | −46 | −19 | −60 | −33 |
| Operating profit/loss | 16 | −10 | −23 | −19 | −37 | −33 |
| Financial items | −8 | −20 | −35 | −37 | −82 | −84 |
| Profit/loss after financial items | 8 | −30 | −58 | −56 | −119 | −117 |
| Appropriations | – | – | – | – | 179 | 179 |
| Profit/loss before tax | 8 | −30 | −58 | −56 | 60 | 62 |
| Tax on profit for the period | – | – | – | – | −19 | −19 |
| Profit/loss for the period | 8 | −30 | −58 | −56 | 41 | 43 |
| SEK million | 2025 30 June |
2024 30 June |
2024 31 Dec |
|---|---|---|---|
| Assets | |||
| Fixed assets | |||
| Intangible assets | 0 | 0 | 0 |
| Financial assets | |||
| Participations in Group companies | 7,432 | 7,212 | 7,212 |
| Receivables from Group companies | 1,580 | 606 | 595 |
| Derivative instruments | 3 | 7 | 5 |
| Total fixed assets | 9,015 | 7,825 | 7,812 |
| Current assets | |||
| Receivables from Group companies | 4,273 | 3,406 | 3,844 |
| Other receivables | 45 | 19 | 26 |
| Prepaid expenses and accrued income | 12 | 13 | 13 |
| Cash and cash equivalents | 0 | 7 | – |
| Total current assets | 4,330 | 3,445 | 3,883 |
| Total assets | 13,345 | 11,270 | 11,695 |
| SEK million | 2025 30 June |
2024 30 June |
2024 31 Dec |
|---|---|---|---|
| Equity and liabilities | |||
| Equity | |||
| Restricted equity | |||
| Share capital | 2 | 2 | 2 |
| Statutory reserve | 0 | 0 | 0 |
| Total restricted equity | 2 | 2 | 2 |
| Non-restricted equity | |||
| Share premium reserve | 1,406 | 1,406 | 1,407 |
| Retained earnings | 737 | 988 | 864 |
| Profit/loss for the period | −58 | −56 | 43 |
| Total non-restricted equity | 2,085 | 2,338 | 2,314 |
| Total equity | 2,087 | 2,340 | 2,316 |
| Untaxed reserves | 117 | 85 | 117 |
| Non-current liabilities | |||
| Liabilities to credit institutions | 2,853 | 1,819 | 1,125 |
| Total non-current liabilities | 2,853 | 1,819 | 1,125 |
| Current liabilities | |||
| Commercial papers | 996 | 573 | 1,037 |
| Accounts payable | 4 | 6 | 9 |
| Tax liabilities | 19 | −1 | 19 |
| Liabilities to Group companies | 7,251 | 6,428 | 7,054 |
| Other liabilities | 1 | 1 | 0 |
| Accrued expenses and deferred income | 17 | 19 | 18 |
| Total current liabilities | 8,288 | 7,026 | 8,137 |
| Total equity and liabilities | 13,345 | 11,270 | 11,695 |
This interim report has been prepared in accordance with IAS 34 Interim Financial Reporting and the Swedish Annual Accounts Act, as well as the Swedish Financial Reporting Board's RFR 1, Supplementary Accounting Rules for Groups, and RFR 2 Accounting for Legal Entities. The accounting policies applied are consistent with those applied in the preparation of the most recent annual report. Since all amounts are rounded, rounding differences can occur.
None of the new or revised standards or interpretations effective from 1 January 2025 had any material impact on the financial statements of the Group or the Parent Company. No new or revised standards have been adopted in advance.
Ambea's operations consist of the following segments:
| SEK million | 2025 Q2 |
2025 Q1 |
2024 Q4 |
2024 Q3 |
2024 Q2 |
2024 Q1 |
2023 Q4 |
2023 Q3 |
2023 Q2 |
|---|---|---|---|---|---|---|---|---|---|
| Net sales | |||||||||
| Nytida | 1,150 | 1,122 | 1,108 | 1,056 | 1,044 | 1,041 | 1,018 | 1,005 | 1,017 |
| Vardaga | 1,358 | 1,313 | 1,306 | 1,288 | 1,262 | 1,231 | 1,200 | 1,159 | 1,131 |
| Stendi | 823 | 823 | 834 | 841 | 840 | 837 | 808 | 806 | 765 |
| Validia | 375 | – | – | – | – | – | – | – | – |
| Altiden | 327 | 333 | 329 | 320 | 311 | 313 | 317 | 326 | 329 |
| Klara | 104 | 100 | 106 | 94 | 104 | 105 | 116 | 106 | 116 |
| Group adjustments | −49 | −47 | −46 | −44 | −42 | −43 | –47 | –47 | –48 |
| Ambea | 4,088 | 3,644 | 3,637 | 3,555 | 3,519 | 3,484 | 3,412 | 3,355 | 3,310 |
| Adjusted EBITA Nytida |
127 | 118 | 121 | 168 | 124 | 125 | 130 | 168 | 134 |
| Vardaga | 115 | 111 | 122 | 161 | 105 | 103 | 88 | 123 | 68 |
| Stendi | 29 | 68 | 93 | 121 | 61 | 59 | 70 | 88 | 19 |
| Validia | 39 | – | – | – | – | – | – | – | – |
| Altiden | 1 | 8 | 10 | 25 | −13 | −9 | −14 | –2 | –18 |
| Klara | 9 | 8 | 11 | 10 | 5 | 9 | 14 | 14 | 13 |
| Unallocated items | −9 | −6 | −13 | −7 | −11 | −8 | –2 | –8 | –25 |
| Ambea | 311 | 307 | 344 | 478 | 271 | 279 | 286 | 383 | 191 |
| April–June 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| SEK million | Nytida | Vardaga | Stendi | Validia | Altiden | Klara | Unallocated items* |
Group adjustments |
Group |
| Operating income | |||||||||
| Net sales | 1,150 | 1,358 | 823 | 375 | 327 | 104 | – | −49 | 4,088 |
| Other operating income | 7 | 32 | 1 | 0 | 2 | – | 1 | – | 43 |
| Total income | 1,157 | 1,390 | 824 | 375 | 329 | 104 | 1 | −49 | 4,131 |
| EBITA | 127 | 115 | 29 | 39 | 1 | 9 | −34 | – | 286 |
| EBITA margin, % | 11.0 | 8.5 | 3.5 | 10.4 | 0.3 | 8.7 | – | – | 7.0 |
| Items affecting comparability | – | – | – | – | – | – | 25 | – | 25 |
| Adjusted EBITA | 127 | 115 | 29 | 39 | 1 | 9 | −9 | – | 311 |
| Adjusted EBITA margin, % | 11.0 | 8.5 | 3.5 | 10.4 | 0.3 | 8.7 | – | – | 7.6 |
| Amortisation of intangible assets | −12 | ||||||||
| Operating profit (EBIT) | 274 | ||||||||
| Net financial items | −136 | ||||||||
| Profit/loss before tax | 138 | ||||||||
| Tax on profit for the period | −43 | ||||||||
| Profit/loss for the period | 95 | ||||||||
| Assets | 6,960 | 7,551 | 2,104 | 2,442 | 1,433 | 303 | 543 | – | 21,336 |
| April–June 2024 | |||||||||
| Unallocated | Group | ||||||||
| SEK million | Nytida | Vardaga | Stendi | Validia | Altiden | Klara | items* | adjustments | Group |
| Operating income Net sales |
1,044 | 1,262 | 840 | – | 311 | 104 | – | −42 | 3,519 |
| Other operating income | 11 | 22 | 1 | – | 6 | – | 3 | – | 43 |
| Total income | 1,056 | 1,284 | 841 | – | 317 | 104 | 3 | −42 | 3,562 |
| EBITA | 124 | 105 | 61 | – | −13 | 5 | −11 | – | 271 |
| EBITA margin, % | 11.9 | 8.3 | 7.3 | – | −4.2 | 4.8 | – | – | 7.7 |
| Items affecting comparability | – | – | – | – | – | – | – | – | – |
| Adjusted EBITA | 124 | 105 | 61 | – | −13 | 5 | −11 | – | 271 |
| Adjusted EBITA margin, % | 11.9 | 8.3 | 7.3 | – | −4.2 | 4.8 | – | – | 7.7 |
| Amortisation of intangible assets | −23 | ||||||||
| Operating profit (EBIT) | 248 | ||||||||
| Net financial items | −118 | ||||||||
| Profit/loss before tax | 130 | ||||||||
| Tax on profit for the period | −35 | ||||||||
| Profit/loss for the period | 95 |
*The 'Unallocated items' column consists of centrally approved costs
| January–June 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| SEK million | Nytida | Vardaga | Stendi | Validia | Altiden | Klara | Unallocated items* |
Group adjustments |
Group |
| Operating income | |||||||||
| Net sales | 2,272 | 2,671 | 1,646 | 375 | 660 | 204 | – | −96 | 7,732 |
| Other operating income | 13 | 54 | 2 | 0 | 3 | 1 | 4 | – | 77 |
| Total income | 2,285 | 2,725 | 1,648 | 375 | 663 | 205 | 4 | −96 | 7,809 |
| EBITA | 245 | 226 | 97 | 39 | 9 | 17 | −70 | – | 563 |
| EBITA margin (%) | 10.8 | 8.5 | 5.9 | 10.4 | 1.4 | 8.3 | – | – | 7.3 |
| Items affecting comparability | – | – | – | – | – | – | 55 | – | 55 |
| Adjusted EBITA | 245 | 226 | 97 | 39 | 9 | 17 | −15 | – | 618 |
| Adjusted EBITA margin, % | 10.8 | 8.5 | 5.9 | 10.4 | 1.4 | 8.3 | – | – | 8.0 |
| Amortisation of intangible assets | −25 | ||||||||
| Operating profit (EBIT) | 538 | ||||||||
| Net financial items | −250 | ||||||||
| Profit/loss before tax | 288 | ||||||||
| Tax on profit for the period | −76 | ||||||||
| Profit/loss for the period | 212 | ||||||||
| Assets | 6,960 | 7,551 | 2,104 | 2,442 | 1,433 | 303 | 543 | – | 21,336 |
| January–June 2024 | |||||||||
| SEK million | Nytida | Vardaga | Stendi | Validia | Altiden | Klara | Unallocated items* |
Group adjustments |
Group |
| Operating income | |||||||||
| Net sales | 2,086 | 2,493 | 1,677 | – | 624 | 209 | – | −86 | 7,003 |
| Other operating income | 21 | 42 | 6 | – | 11 | – | 4 | – | 84 |
| Total income | 2,106 | 2,535 | 1,683 | – | 635 | 209 | 4 | −86 | 7,087 |
| EBITA | 249 | 208 | 120 | – | −22 | 14 | −19 | – | 550 |
| EBITA margin (%) | 11.9 | 8.3 | 7.2 | – | −3.5 | 6.7 | – | – | 7.9 |
| Items affecting comparability | – | – | – | – | – | – | – | – | – |
| Adjusted EBITA | 249 | 208 | 120 | – | −22 | 14 | −19 | – | 550 |
| Adjusted EBITA margin, % | 11.9 | 8.3 | 7.2 | – | −3.5 | 6.7 | – | – | 7.9 |
| Amortisation of intangible assets | −46 | ||||||||
| Operating profit (EBIT) | 504 | ||||||||
| Net financial items | −233 | ||||||||
| Profit/loss before tax | 271 | ||||||||
| Tax on profit for the period | −65 | ||||||||
| Profit/loss for the period | 206 | ||||||||
| Assets | 6,589 | 7,810 | 2,051 | – | 1,579 | 340 | 152 | 0 | 18,521 |
*The 'Unallocated items' column consists of centrally approved costs
| Type of service delivery (April–June) | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nytida | Vardaga | Stendi | Validia | Altiden | Klara | Group eliminations |
Group | |||||||||
| SEK million | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
| Own Management | 929 | 841 | 932 | 865 | 823 | 840 | 375 | – | 241 | 222 | – | – | – | – | 3,300 | 2,768 |
| Contract Management | 221 | 203 | 426 | 397 | – | – | – | – | 86 | 89 | – | – | – | – | 733 | 689 |
| Competence and staffing solutions | 0 | – | 0 | – | – | – | – | – | – | – | 104 | 104 | −49 | −42 | 55 | 62 |
| Total | 1,150 | 1,044 | 1,358 | 1,262 | 823 | 840 | 375 | – | 327 | 311 | 104 | 104 | −49 | −42 | 4,088 | 3,519 |
| Income | ||||||||||||||||
| External customers | 1,150 | 1,044 | 1,358 | 1,262 | 823 | 840 | 375 | – | 327 | 311 | 55 | 61 | – | – | 4,088 | 3,519 |
| Revenue between segments | – | – | – | – | – | – | – | – | – | – | 49 | 42 | −49 | −42 | – | – |
| Total | 1,150 | 1,044 | 1,358 | 1,262 | 823 | 840 | 375 | – | 327 | 311 | 104 | 104 | −49 | −42 | 4,088 | 3,519 |
| Nytida | Vardaga | Stendi | Validia | Altiden | Klara | Group eliminations |
Group | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SEK million | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
| Own Management | 1,840 | 1,675 | 1,830 | 1,709 | 1,646 | 1,643 | 375 | – | 487 | 441 | – | – | – | – | 6,178 | 5,468 |
| Contract Management | 432 | 411 | 841 | 784 | – | 34 | – | – | 173 | 182 | – | – | – | – | 1,446 | 1,411 |
| Competence and staffing solutions | – | – | – | – | – | – | – | – | – | – | 204 | 209 | −96 | −86 | 108 | 124 |
| Total | 2,272 | 2,086 | 2,671 | 2,493 | 1,646 | 1,677 | 375 | – | 660 | 624 | 204 | 209 | −96 | −86 | 7,732 | 7,003 |
| Income | ||||||||||||||||
| External customers | 2,272 | 2,086 | 2,671 | 2,493 | 1,646 | 1,677 | 375 | – | 660 | 624 | 108 | 123 | – | – | 7,732 | 7,003 |
| Revenue between segments | – | – | – | – | – | – | – | – | – | – | 96 | 86 | −96 | −86 | – | – |
| Total | 2,272 | 2,086 | 2,671 | 2,493 | 1,646 | 1,677 | 375 | – | 660 | 624 | 204 | 209 | −96 | −86 | 7,732 | 7,003 |
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Jun |
|---|---|---|---|---|---|---|
| Acquisition-related costs | 25 | – | 55 | – | 55 | – |
| Total items affecting comparability | 25 | – | 55 | – | 55 | – |
On 1 April, Validia Oy was acquired, which operates residential care and support for people with disabilities in Finland. The acquisition includes approximately 50 care units, 1,400 beds and 2,600 employees. The consideration amounted to SEK 1,440 million, of which SEK 220 million was paid in own shares. Transaction costs in connection with the acquisition amounted to SEK 55 million at 30 June, and was recognised as other external costs affecting comparability. The acquisition analysis is preliminary as some work remains before it is completed. The amounts are based on the exchange rate at 1 April, EUR/SEK 10.8160. Since the acquisition date, Validia has contributed SEK 375 million to net sales, and SEK 38 million to profit before tax. If the acquisition had taken place on 1 January 2025, Validia would have contributed SEK 737 million to net sales and SEK 71 million to profit before tax.
On 5 May, parts of the care provider AvAsta were acquired. The acquisition comprises the Sisjödal nursing home as well as AvAsta's four units providing care for adults with lifelong disabilities and social problems. The consideration amounted to SEK 121 million. Transaction costs in connection with the acquisition amounted to SEK 2 million, and was recognised as other external costs. The acquisition analysis is preliminary as some work remains before it is completed. Since the acquisition date, the companies have contributed SEK 26 million to net sales and SEK 3 million to profit before tax. If the acquisition had taken place on 1 January 2025, the companies would have contributed SEK 73 million to net sales and SEK 7 million to profit before tax.
| SEK million | Validia | AvAsta | Total |
|---|---|---|---|
| The carrying amount of net identifiable assets excl. intangible assets |
196 | 14 | 210 |
| Intangible assets and Group goodwill | 1,244 | 107 | 1,351 |
| Total consideration (price of shares) | 1,440 | 121 | 1,561 |
| Less: cash and cash equivalents | −140 | −25 | −165 |
| Less: payment with own shares | −220 | – | −220 |
| Net change in cash | 1,080 | 96 | 1,176 |
| SEK million | Validia | AvAsta | Total |
|---|---|---|---|
| Fixed assets | 91 | 4 | 95 |
| Right-of-use assets | 919 | 239 | 1,158 |
| Accounts receivable and other receivables | 149 | 29 | 178 |
| Cash and cash equivalents | 140 | 25 | 165 |
| Non-current liabilities and provisions | 0 | – | 0 |
| Deferred tax liability | – | – | – |
| Lease liabilities | −919 | −239 | −1,158 |
| Accounts payable and other liabilities | −184 | −44 | −228 |
| Net identifiable assets | 196 | 14 | 210 |
| Date | Acquisitions | Operations | Segments | Annual sales |
|---|---|---|---|---|
| 1 Apr 2025 | Validia | Residential care and support for people with disabilities | Validia | SEK 1,395 million |
| 5 May 2025 | AvAsta | Elderly care, residential care and support for people with disabilities | Nytida and Vardaga | SEK 144 million |
| Classification in the fair value hierarchy | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||||
| SEK million | 2025 30 June |
2024 30 June |
2025 30 June |
2024 30 June |
2025 30 June |
2024 30 June |
2025 30 June |
2024 30 June |
| Assets | ||||||||
| Interest-rate derivatives | – | 13 | – | – | – | 13 | – | – |
| Investments in housing coopera tive associations |
88 | 88 | – | – | – | – | 88 | 88 |
| Total | 88 | 101 | – | – | – | 13 | 88 | 88 |
| Liabilities | ||||||||
| Interest-rate derivatives | 3 | – | – | – | 3 | – | – | – |
| Total | 3 | – | – | – | 3 | – | – | – |
Ambea applies the following hierarchy for the fair value measurement of financial instruments:
Ambea has borrowings/loans in Swedish, Norwegian and Danish kronor and is thereby exposed to interest-rate risk. According to the company's Financial Policy, at least 50 per cent of the interest-rate risk should be hedged. To reduce the company's interest-rate risk, the company uses different types of interest-rate hedging products (interest-rate derivatives). The hedges have a remaining term of up to three years. In total, about 51 per cent of the company's average interest-bearing liabilities within 12 months have been hedged with interest-rate derivatives.
Derivatives are classified as Level 2 assets in the fair value hierarchy. The change in fair value of the interest-rate cap and interest-rate swap was recognised in other comprehensive income. Ambea uses standard bank pricing models for the valuation of purchased interest-rate caps and interest-rate swaps. The valuation is based on the bank's standard pricing model and methodology. The valuation is based on the bank's average price.
There have been no changes between the levels since the most recent annual report.
| SEK million | 2025 30 June |
2024 30 June |
2024 31 Dec |
|---|---|---|---|
| Tax dispute | 14 | 14 | 14 |
| Total contingent liabilities | 14 | 14 | 14 |
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Growth/Acquired growth | ||||||
| Net sales growth (%) | 16.2 | 6.3 | 10.4 | 7.0 | 8.4 | 6.6 |
| Of which organic growth (%) | 4.9 | 5.9 | 4.6 | 6.8 | 5.4 | 6.5 |
| Of which acquired/divested growth (%) | 13.1 | 0.1 | 7.5 | 0.0 | 4.3 | 0.5 |
| Of which currency and calendar effect (%) | −1.8 | 0.3 | −1.7 | 0.2 | −1.3 | −0.4 |
| Operating margin (EBIT) | ||||||
| Net sales | 4,088 | 3,519 | 7,732 | 7,003 | 14,924 | 14,195 |
| Operating profit (EBIT) | 274 | 248 | 538 | 504 | 1,312 | 1,278 |
| Operating margin, EBIT (%) | 6.7 | 7.0 | 7.0 | 7.2 | 8.8 | 9.0 |
| EBITA and adjusted EBITA | ||||||
| Operating profit (EBIT) | 274 | 248 | 538 | 504 | 1,312 | 1,278 |
| Amortisation and impairment of intangible assets | 12 | 23 | 25 | 46 | 73 | 94 |
| EBITA | 286 | 271 | 563 | 550 | 1,385 | 1,372 |
| Items affecting comparability | 25 | – | 55 | – | 55 | – |
| Adjusted EBITA | 311 | 271 | 618 | 550 | 1,440 | 1,372 |
| Net sales | 4,088 | 3,519 | 7,732 | 7,003 | 14,924 | 14,195 |
| EBITA margin (%) | 7.0 | 7.7 | 7.3 | 7.9 | 9.3 | 9.7 |
| Adjusted EBITA margin (%) | 7.6 | 7.7 | 8.0 | 7.9 | 9.6 | 9.7 |
| EBITDA and adjusted EBITDA | ||||||
| Operating profit (EBIT) | 274 | 248 | 538 | 504 | 1,312 | 1,278 |
| Depreciation, amortisation and impairment of tangible and intangible assets |
376 | 342 | 719 | 679 | 1,407 | 1,367 |
| EBITDA | 650 | 590 | 1,257 | 1,183 | 2,719 | 2,645 |
| Items affecting comparability | 25 | – | 55 | – | 55 | – |
| Adjusted EBITDA | 675 | 590 | 1,312 | 1,183 | 2,774 | 2,645 |
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| EBITDA and adjusted EBITDA, excluding IFRS 16 effects | ||||||
| Operating profit (EBIT) | 274 | 248 | 538 | 504 | 1,312 | 1,278 |
| Depreciation, amortisation and impairment of tangible and intangible assets |
376 | 342 | 719 | 679 | 1,407 | 1,367 |
| Less: Rental payments Properties | −380 | −334 | −720 | −661 | −1,391 | −1,332 |
| Less: Rental payments Vehicles | −19 | −18 | −39 | −34 | −76 | −71 |
| Less Capital loss from contracts terminated | −1 | −1 | −3 | −2 | −6 | −5 |
| Net effects of IFRS 16 on EBITDA | −400 | −353 | −762 | −697 | −1,473 | −1,408 |
| EBITDA excluding IFRS 16 effects | 250 | 237 | 495 | 486 | 1,246 | 1,237 |
| Items affecting comparability | 25 | – | 55 | – | 55 | – |
| Adjusted EBITDA excluding IFRS 16 effects | 275 | 237 | 550 | 486 | 1,301 | 1,237 |
| EBITA and adjusted EBITA, excluding IFRS 16 effects Operating profit (EBIT) Amortisation and impairment of intangible assets |
274 12 |
248 23 |
538 25 |
504 46 |
1,312 73 |
1,278 94 |
| EBITA | 286 | 271 | 563 | 550 | 1,385 | 1,372 |
| Plus IFRS 16 depreciation | 337 | 296 | 642 | 587 | 1,235 | 1,180 |
| Less: Rental payments Properties | −380 | −334 | −720 | −661 | −1,391 | −1,332 |
| Less: Rental payments Vehicles | −19 | −18 | −39 | −34 | −76 | −71 |
| Less Capital loss from contracts terminated | −1 | −1 | −3 | −2 | −6 | −5 |
| Net effects of IFRS 16 on EBITA | −63 | −57 | −120 | −110 | −238 | −228 |
| EBITA excluding IFRS 16 effects | 223 | 214 | 443 | 440 | 1,147 | 1,144 |
| Items affecting comparability | 25 | – | 55 | – | 55 | – |
| Adjusted EBITA excluding IFRS 16 effects | 248 | 214 | 498 | 440 | 1,202 | 1,144 |
| EBITA margin, excluding IFRS 16 effects | 5.5 | 6.1 | 5.7 | 6.3 | 7.7 | 8.1 |
| Adjusted EBITA margin, excluding IFRS 16 effects | 6.1 | 6.1 | 6.4 | 6.3 | 8.1 | 8.1 |
| SEK million | 2025 Apr–Jun |
2024 Apr–Jun |
2025 Jan–Jun |
2024 Jan–Jun |
RTM | 2024 Jan–Dec |
|---|---|---|---|---|---|---|
| Operating cash flow | ||||||
| EBITDA | 650 | 590 | 1,257 | 1,183 | 2,719 | 2,645 |
| Adjustment for non-cash items | −1 | −8 | −11 | −27 | −65 | −81 |
| Cash flow from investing activities excl. acquisitions and investments in financial instruments |
−29 | −32 | −72 | −47 | −125 | −100 |
| Adjustment for cash flow from investing activities related to increased capacity/growth |
0 | 15 | 0 | 16 | 3 | 19 |
| Change in working capital | −10 | 40 | −137 | 60 | −90 | 107 |
| Operating cash flow | 610 | 605 | 1,037 | 1,185 | 2,442 | 2,590 |
| Cash conversion (%) | ||||||
| Operating cash flow | 610 | 605 | 1,037 | 1,185 | 2,442 | 2,590 |
| EBITDA | 650 | 590 | 1,257 | 1,183 | 2,719 | 2,645 |
| Cash conversion (%) | 93.8 | 102.5 | 82.5 | 100.2 | 89.8 | 97.9 |
| Items affecting comparability | ||||||
| Reversal of acquisition-related costs | ||||||
| – of which costs included in the line item of other external costs | 25 | – | 55 | – | 55 | – |
| Total acquisition-related costs | 25 | – | 55 | – | 55 | – |
| Total items affecting comparability | 25 | – | 55 | – | 55 | – |
| SEK million | 2025 30 June |
2024 30 June |
2024 31 Dec |
|---|---|---|---|
| Net debt, Net debt/Adjusted EBITDA, RTM | |||
| Non-current interest-bearing liabilities | 10,377 | 9,720 | 8,878 |
| Current interest-bearing liabilities | 3,302 | 1,690 | 2,177 |
| Less: cash and cash equivalents | −247 | −39 | −28 |
| Net debt | 13,432 | 11,371 | 11,027 |
| Adjusted EBITDA RTM | 2,774 | 2,467 | 2,645 |
| Net debt/Adjusted EBITDA, RTM (times) | 4.8 | 4.6 | 4.2 |
| Net debt, Net debt/Adjusted EBITDA, RTM excl. IFRS 16 effects Non-current interest-bearing liabilities |
10,377 | 9,720 | 8,878 |
| Less: non-current lease liabilities pertaining to properties, recognised on the lease liabilities line |
−8,389 | −7,735 | −7,568 |
| Less: non-current lease liabilities pertaining to vehicles, recognised on the lease liabilities line | −195 | −195 | −223 |
| Current interest-bearing liabilities | 3,302 | 1,690 | 2,177 |
| Less: current lease liabilities pertaining to properties recognised on the lease liabilities line | −1,199 | −1,034 | −1,062 |
| Less: current lease liabilities pertaining to vehicles, recognised on the lease liabilities line | −104 | −83 | −76 |
| Less: cash and cash equivalents | −247 | −39 | −28 |
| Net debt, excluding IFRS 16 effects | 3,545 | 2,324 | 2,098 |
| Adjusted EBITDA RTM | 1,301 | 1,101 | 1,237 |
| Net debt/Adjusted EBITDA, RTM (times) | 2.7 | 2.1 | 1.7 |
IVO quality inspections: The IVO carried out 30 inspections in Nytida and no inspections in Vardaga. During the quarter, the IVO issued decisions in 14 quality inspections in Nytida, one of which resulted in remarks. During the quarter, a decision was issued in Vardaga from an earlier quality inspection that resulted in remarks.
Lex Sarah reports: A total of ten Lex Sarah reports were lodged, seven by Nytida and three by Vardaga. Seven decisions have been issued and all were closed without any remarks.
Lex Maria reports: Five Lex Maria reports were lodged in Sweden, one in Nytida and four in Vardaga. A decision was issued during the quarter and was closed without any remarks.
Individual complaints investigated by the IVO: No individual complaints were lodged in relation to Vardaga or Nytida during the quarter. Two decisions from previous years were issued during the quarter, one of which resulted in remarks.
Regulatory inspections based on quality management: A total of 49 inspections were carried out in Norway during the quarter. 45 of these pertained to services for children and four to care services for adults. No inspections were performed in personal assistance. Five of the inspections resulted in remarks, three in children's units and two in care services.
A total of eight quality inspections were carried out in Validia's operations, seven by the wellbeing services counties and one by Kela (the Social Insurance Institution of Finland). While all of these quality inspections contained remarks, none of the discrepancies were deemed to be serious.
Regulatory inspections based on quality management: In Altiden, 35 quality inspections were carried out, seven in elderly care and 28 in social care. A total of two of the inspections resulted in remarks.
The Swedish Data Protection Officer notified the IMY of four personal data breaches during the quarter. None of them posed, or were deemed to pose, a serious risk to the data subjects. In all cases, relevant measures were taken immediately to prevent any recurrence by raising awareness and competence in regard to existing procedures and work processes. The IMY has issued decisions on three cases related to the second quarter, and does not intend to take any further action.
No reports were made to the Data Protection Authority in Norway and one report was made in Denmark.
A report was made to the Office of the Data Protection Ombudsman in Finland, but no action is being taken.
The Swedish Health and Social Care Inspectorate (IVO):
The IVO is a government agency responsible for supervising social care in Sweden, including healthcare and social services. The agency's mission is to ensure that elderly and social care maintains high quality and is provided in accordance with legislation. The agency is also responsible for issuing permits to private care providers.
Lex Sarah: A reporting obligation in social services and under LSS (Act on Support and Service to Persons with Certain Functional Disabilities) entailing that employees are obligated to report serious misconduct or risks of such misconduct. These reports are made to the IVO, with the aim of improving the quality of the activity and protecting the rights of the individual.
Lex Maria: A reporting obligation in healthcare that requires care providers to report incidents that have caused, or could have caused, serious injury to a patient. These reports are made to the IVO, with the aim of improving patient safety through systematic measures.
The Swedish Authority for Privacy Protection (IMY): The IMY reviews and enforces the application of data protection rules, including the GDPR. The agency works with issues related to data protection and has been tasked with strengthening the privacy rights of individuals in digital environments.

We make the world a better place, one person at a time.

Have a question? We'll get back to you promptly.